Abl Diagnostics Sa Stock Fundamentals

ABLD Stock   2.40  0.10  4.00%   
AbL Diagnostics SA fundamentals help investors to digest information that contributes to AbL Diagnostics' financial success or failures. It also enables traders to predict the movement of AbL Stock. The fundamental analysis module provides a way to measure AbL Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AbL Diagnostics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AbL Diagnostics SA Company Shares Owned By Insiders Analysis

AbL Diagnostics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current AbL Diagnostics Shares Owned By Insiders

    
  12.08 %  
Most of AbL Diagnostics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AbL Diagnostics SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 12.08% of AbL Diagnostics SA are shares owned by insiders. This is 26.65% lower than that of the Industrials sector and notably higher than that of the Railroads industry. The shares owned by insiders for all France stocks is 19.72% lower than that of the firm.

AbL Diagnostics SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AbL Diagnostics's current stock value. Our valuation model uses many indicators to compare AbL Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AbL Diagnostics competition to find correlations between indicators driving AbL Diagnostics's intrinsic value. More Info.
AbL Diagnostics SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AbL Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AbL Diagnostics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

AbL Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AbL Diagnostics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AbL Diagnostics could also be used in its relative valuation, which is a method of valuing AbL Diagnostics by comparing valuation metrics of similar companies.
AbL Diagnostics is currently under evaluation in shares owned by insiders category among its peers.

AbL Fundamentals

About AbL Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AbL Diagnostics SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbL Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbL Diagnostics SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in AbL Stock

AbL Diagnostics financial ratios help investors to determine whether AbL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbL with respect to the benefits of owning AbL Diagnostics security.